SEPTInvestingStart Free

INM SCHEDULE 13D: Activist campaign

Fairmount Funds Management LLC and affiliates

Filed with the SEC on · accession 0001193125-26-458677

INM filed a SCHEDULE 13D (schedule 13d) with the SEC on Nov 12, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Fairmount Funds Management LLC and affiliates filed a Schedule 13D disclosing beneficial ownership of 10,555,507 shares, or 19.99%, of InMed Pharmaceuticals (Mentari Therapeutics) common stock, subject to beneficial ownership limitations on convertible preferred stock and pre-funded warrants.

For details, click here →

Key details

Shares of common stock directly held by Fund II$10.6M
Shares issuable upon conversion of Series A Preferred Stock$4.0M
Shares issuable upon exercise of Pre-Funded Warrants$1.5M
Total outstanding shares of common stock as of November 6, 2026$52.8M
Reporting person / investment adviserFairmount Funds Management LLC
Direct holder of 10,555,507 sharesFairmount Healthcare Fund II L.P.
Subject companyInMed Pharmaceuticals Inc. (Mentari Therapeutics, Inc.)
Reporting person / fairmount principalPeter Evan Harwin
Reporting person / fairmount principalTomas Kiselak

✦ Ask GOAX AI about this filing — what it means for INM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INM?

Click here

Frequently asked questions

What did INM file with the SEC on Nov 12, 2026?

INM filed a SCHEDULE 13D (Activist campaign). Fairmount Funds Management LLC and affiliates filed a Schedule 13D disclosing beneficial ownership of 10,555,507 shares, or 19.99%, of InMed Pharmaceuticals (Mentari Therapeutics) common stock, subject to beneficial ownership limitations on convertible preferred stock and pre-funded warrants.

What does a activist campaign mean for INM stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).

Other INM SEC filings

Get alerts when INM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
INM overviewINM analysisINM newsLatest SEC filings